Tranilast

A pharmaceutical candidate for reduction of adhesions using a novel approach

Janel Petrilli, Scott Wadsworth, Kevin Cooper, Kathleen E. Rodgers, John Siekierka, Gere S. DiZerega

Research output: Contribution to journalReview articleResearchpeer-review

4 Citations (Scopus)

Abstract

Postsurgical adhesion formation has numerous deleterious side effects in a wide variety of surgical settings. Physical barriers used together with laparoscopy were developed in hopes of reducing the tissue trauma seen with open procedures and separating tissues during the critical time of healing to reduce adhesion formation. Despite meticulous techniques by surgeons and the availability of barriers, adhesion formation remains a serious problem, with more than $1 billion spent annually on complications arising from adhesions. Our laboratories have combined a previously marketed drug, Tranilast, with a gel to provide a locally delivered medicated device that can reduce adhesion formation. This article will review the role of Tranilast in the key pathways involved in adhesion formation.

Original languageEnglish
Pages (from-to)341-348
Number of pages8
JournalSeminars in Reproductive Medicine
Volume26
Issue number4
DOIs
StatePublished - 1 Jul 2008

Fingerprint

Architectural Accessibility
Pharmaceutical Preparations
Laparoscopy
Gels
Equipment and Supplies
Wounds and Injuries
tranilast
Surgeons

Keywords

  • Adhesions
  • Gynecologic surgery
  • Mast cells
  • Surgery
  • Transilast

Cite this

Petrilli, Janel ; Wadsworth, Scott ; Cooper, Kevin ; Rodgers, Kathleen E. ; Siekierka, John ; DiZerega, Gere S. / Tranilast : A pharmaceutical candidate for reduction of adhesions using a novel approach. In: Seminars in Reproductive Medicine. 2008 ; Vol. 26, No. 4. pp. 341-348.
@article{7033f2da2eb747bcb6bf6eec86eea4c1,
title = "Tranilast: A pharmaceutical candidate for reduction of adhesions using a novel approach",
abstract = "Postsurgical adhesion formation has numerous deleterious side effects in a wide variety of surgical settings. Physical barriers used together with laparoscopy were developed in hopes of reducing the tissue trauma seen with open procedures and separating tissues during the critical time of healing to reduce adhesion formation. Despite meticulous techniques by surgeons and the availability of barriers, adhesion formation remains a serious problem, with more than $1 billion spent annually on complications arising from adhesions. Our laboratories have combined a previously marketed drug, Tranilast, with a gel to provide a locally delivered medicated device that can reduce adhesion formation. This article will review the role of Tranilast in the key pathways involved in adhesion formation.",
keywords = "Adhesions, Gynecologic surgery, Mast cells, Surgery, Transilast",
author = "Janel Petrilli and Scott Wadsworth and Kevin Cooper and Rodgers, {Kathleen E.} and John Siekierka and DiZerega, {Gere S.}",
year = "2008",
month = "7",
day = "1",
doi = "10.1055/s-0028-1082392",
language = "English",
volume = "26",
pages = "341--348",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "4",

}

Tranilast : A pharmaceutical candidate for reduction of adhesions using a novel approach. / Petrilli, Janel; Wadsworth, Scott; Cooper, Kevin; Rodgers, Kathleen E.; Siekierka, John; DiZerega, Gere S.

In: Seminars in Reproductive Medicine, Vol. 26, No. 4, 01.07.2008, p. 341-348.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Tranilast

T2 - A pharmaceutical candidate for reduction of adhesions using a novel approach

AU - Petrilli, Janel

AU - Wadsworth, Scott

AU - Cooper, Kevin

AU - Rodgers, Kathleen E.

AU - Siekierka, John

AU - DiZerega, Gere S.

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Postsurgical adhesion formation has numerous deleterious side effects in a wide variety of surgical settings. Physical barriers used together with laparoscopy were developed in hopes of reducing the tissue trauma seen with open procedures and separating tissues during the critical time of healing to reduce adhesion formation. Despite meticulous techniques by surgeons and the availability of barriers, adhesion formation remains a serious problem, with more than $1 billion spent annually on complications arising from adhesions. Our laboratories have combined a previously marketed drug, Tranilast, with a gel to provide a locally delivered medicated device that can reduce adhesion formation. This article will review the role of Tranilast in the key pathways involved in adhesion formation.

AB - Postsurgical adhesion formation has numerous deleterious side effects in a wide variety of surgical settings. Physical barriers used together with laparoscopy were developed in hopes of reducing the tissue trauma seen with open procedures and separating tissues during the critical time of healing to reduce adhesion formation. Despite meticulous techniques by surgeons and the availability of barriers, adhesion formation remains a serious problem, with more than $1 billion spent annually on complications arising from adhesions. Our laboratories have combined a previously marketed drug, Tranilast, with a gel to provide a locally delivered medicated device that can reduce adhesion formation. This article will review the role of Tranilast in the key pathways involved in adhesion formation.

KW - Adhesions

KW - Gynecologic surgery

KW - Mast cells

KW - Surgery

KW - Transilast

UR - http://www.scopus.com/inward/record.url?scp=50249103450&partnerID=8YFLogxK

U2 - 10.1055/s-0028-1082392

DO - 10.1055/s-0028-1082392

M3 - Review article

VL - 26

SP - 341

EP - 348

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 4

ER -